| Secondary |
| Migraine |
18.0% |
| Osteoarthritis |
12.1% |
| Product Used For Unknown Indication |
10.4% |
| Asthma |
9.0% |
| Rheumatoid Arthritis |
6.2% |
| Epilepsy |
5.6% |
| Hypertension |
4.5% |
| Deep Vein Thrombosis |
4.2% |
| Ill-defined Disorder |
3.9% |
| Drug Use For Unknown Indication |
3.7% |
| Hypothyroidism |
3.4% |
| Prophylaxis |
3.4% |
| Pain |
3.1% |
| Blood Electrolytes Abnormal |
2.2% |
| Blood Cholesterol Increased |
2.0% |
| Acute Lymphocytic Leukaemia Recurrent |
1.7% |
| Bone Disorder |
1.7% |
| Menstrual Disorder |
1.7% |
| Multiple Myeloma |
1.7% |
| Nausea |
1.7% |
|
| Dyspnoea |
18.2% |
| Cerebrovascular Accident |
13.6% |
| Hyperemesis Gravidarum |
13.6% |
| Rheumatoid Arthritis |
11.4% |
| Peripheral Coldness |
6.8% |
| Diarrhoea |
4.5% |
| Stomatitis |
4.5% |
| Treatment Failure |
4.5% |
| Cardiac Death |
2.3% |
| Lupus-like Syndrome |
2.3% |
| Nephritis Interstitial |
2.3% |
| Pancytopenia |
2.3% |
| Renal Failure Acute |
2.3% |
| Renal Injury |
2.3% |
| Sputum Discoloured |
2.3% |
| Systemic Lupus Erythematosus |
2.3% |
| Vascular Anomaly |
2.3% |
| Walking Aid User |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.1% |
| Product Used For Unknown Indication |
23.2% |
| Rheumatoid Arthritis |
15.6% |
| Osteoporosis |
5.7% |
| Hypertension |
3.7% |
| Pain |
3.2% |
| Crohn's Disease |
3.1% |
| Prophylaxis |
2.5% |
| Hiv Infection |
1.1% |
| Asthma |
1.1% |
| Premedication |
1.1% |
| Depression |
1.1% |
| Nausea |
1.0% |
| Osteoporosis Prophylaxis |
1.0% |
| Ill-defined Disorder |
0.9% |
| Diabetes Mellitus |
0.9% |
| Plasma Cell Myeloma |
0.8% |
| Hypercholesterolaemia |
0.7% |
| Breast Cancer Metastatic |
0.7% |
| Atrial Fibrillation |
0.6% |
|
| Vomiting |
9.3% |
| Death |
9.0% |
| Pneumonia |
8.7% |
| Basal Cell Carcinoma |
6.2% |
| Pulmonary Embolism |
6.2% |
| Urinary Tract Infection |
5.9% |
| Cerebrovascular Accident |
4.3% |
| Herpes Zoster |
4.3% |
| Myocardial Infarction |
4.3% |
| Progressive Multifocal Leukoencephalopathy |
4.3% |
| Pyrexia |
4.3% |
| Nausea |
4.0% |
| Renal Failure |
4.0% |
| Urinary Retention |
4.0% |
| Muscular Weakness |
3.7% |
| Weight Decreased |
3.7% |
| Osteonecrosis |
3.4% |
| Rash |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Sepsis |
3.4% |
|
| Interacting |
| Insomnia |
19.1% |
| Depression |
14.9% |
| Contraception |
12.8% |
| Fatigue |
12.8% |
| Osteopenia |
12.8% |
| Multiple Sclerosis |
6.4% |
| Glomerulonephritis |
4.3% |
| Lower Respiratory Tract Infection |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Drug Use For Unknown Indication |
2.1% |
| Peripheral Coldness |
2.1% |
| Prophylaxis |
2.1% |
| Proteinuria |
2.1% |
|
| Rash Erythematous |
30.0% |
| Swelling |
30.0% |
| Treatment Failure |
20.0% |
| Drug Interaction |
10.0% |
| Tremor |
10.0% |
|
